Investigational Site Number 840350 — Chapel Hill, North Carolina

Investigational Site Number 840350 is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 840350 has participated in 1 clinical trials.

Therapeutic areas: Squamous Cell Lung Cancer.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840350?

Investigational Site Number 840350 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840350 conducted?

Investigational Site Number 840350 has 1 clinical trials on record. Their work covers Squamous Cell Lung Cancer.

Is Investigational Site Number 840350 accredited by Crixeo Health?

Investigational Site Number 840350 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840350?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.